Abstract #0803

First in Human: MRI-guided radiation therapy of the heart with implantable cardiac defibrillator

H Michael Gach¹, Olga L Green², Phillip S Cuculich³, Erin J Wittland⁴, Areti Marko⁴, Molly E Luchtefeld⁴, Jill M Entwistle⁴, Deshan Yang⁵, David J Wilber⁶, Sasa Mutic², and Clifford G Robinson²

¹Radiation Oncology, Radiology, and Biomedical Engineering, Washington University in St Louis, St Louis, MO, United States, ²Radiation Oncology, Washington University in St Louis, St Louis, MO, United States, ³Cardiovascular Diseases and Electrophysiology, Washington University in St Louis, St Louis, MO, United States, ⁴Radiation Oncology, Barnes Jewish Hospital, St Louis, MO, United States, ⁵Radiation Oncology and Biomedical Engineering, Washington University in St Louis, St Louis, MO, United States, ⁶Cardiology, Loyola University Medical Center, Maywood, IL, United States

Low-field (0.35 T) magnetic resonance imaging guided radiation therapy (MR-IGRT) was used for the first time to treat a patient with a cardiovascular implantable electronic device (CIED) and a cardiac fibroma located on the left ventricle. Stereotactic body radiation therapy (SBRT) was delivered in 5 fractions at a dose of 700 cGy/fraction with MRI-based real-time tumor tracking and beam gating. Lessons learned include the need for metal artifact suppression, higher MRI temporal resolution, and MRI safety workflows adapted to radiation oncology.

This abstract and the presentation materials are available to members only; a login is required.

Join Here